OGN:NYSE
Organon & Co
13,74 US$
arrow_upward
+0,07%(+0,010) 1D
13,74 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 29 სექ, 16:00:09 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
13,73 US$
High
13,75 US$
Low
13,72 US$
Mkt. cap
3,61 მლრდ.
Avg. vol.
2,90 მლნ.
Volume
0,00
Dividend
0,58%
Quarterly dividend
0,02 US$
Ex-dividend date
14 აგვ. 2026
P/E ratio
17,60
52-wk high
13,78 US$
52-wk low
5,69 US$
EPS
0,78 US$
Beta
1,52
Shares outstanding
262,61 მლნ.
No. of employees
10 ათ.
Open
13,73 US$
High
13,75 US$
Low
13,72 US$
Mkt. cap
3,61 მლრდ.
Avg. vol.
2,90 მლნ.
Volume
0,00
Dividend
0,58%
Quarterly dividend
0,02 US$
Ex-dividend date
14 აგვ. 2026
P/E ratio
17,60
52-wk high
13,78 US$
52-wk low
5,69 US$
EPS
0,78 US$
Beta
1,52
Shares outstanding
262,61 მლნ.
No. of employees
10 ათ.
News stories
From web sources and news partners
Simply Wall St
·
6 საათის წინ
What Comes Next For Organon (OGN) After A 30% Gain
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 ათ.
Founded1923
HeadquartersJersey City, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Websiteorganon.com